Nonalcoholic Fatty Liver Disease: From Molecular Mechanisms to Therapeutic Approaches
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 2604
Special Issue Editors
Interests: peptides; secondary metabolites; nutraceuticals; interactions between small molecules; enzymes; obesity; cytotoxicity; anti-HIV; analytical methods; LC-MS; NMR
Special Issues, Collections and Topics in MDPI journals
Interests: non-alcoholic fatty liver disease; diabetes; mitochondrial uncouplers; mouse models of metabolic disease; obesity; energy metabolism
Special Issue Information
Dear Colleagues,
Nonalcoholic fatty liver disease, or NAFLD, refers to a liver problem that affects human beings who drink little to no alcohol, and it is becoming more common, especially in Middle Eastern and Western countries, with increasing rates of obesity. In recent years, great efforts have been made to investigate the pathogenesis of NAFLD; accordingly, a large quantity of biomolecules (small synthetic molecules, natural products, active peptides, oligonucleotide, etc.) with decent activities have been discovered as promising therapeutics through a variety of mechanisms, such as mitochondrial uncouplers, fibroblast growth factor activators, etc. Therefore, this Special Issue aims to publish submissions covering either the identification of biomolecules with promising therapeutic effects or mechanistic studies of biomolecules targeting NAFLD.
Dr. Yumin Dai
Dr. Martina Beretta
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nonalcoholic fatty liver disease (NAFLD)
- non-alcoholic steatohepatitis (NASH)
- reactive oxygen species
- mitochondria
- lipotoxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
